Melincoff Gwen A bought PLX
September 3, 2025 · Form 4 insider transaction
Melincoff Gwen A bought 15,000 shares of Protalix BioTherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant.; Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $3.55 per share that expire on January 20, 2030, (ii) options to purchase 50,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032 and (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033.